PDT Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
HRCM
GS
OAM
PDT Partners's CDNA Position: Q2 2025 in Review
PDT Partners sold out of CareDx (CDNA) in Q2 2025, closing a stake of 70,097 shares — an estimated $1.24M sold.
PDT Partners first reported a position in CDNA in Q1 2018 and held it in 19 quarters. The position peaked at $5.65M in Q4 2020. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.
- PDT Partners reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
- PDT Partners sold 70,097 CareDx shares in Q2 2025, an estimated $1.24M.
- PDT Partners first reported a position in CareDx in Q1 2018 and held it in 19 quarters.
- PDT Partners's CareDx position peaked at $5.65M in Q4 2020.
- 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.
Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.